Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-07-10
1998-11-17
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514887, 514969, A61K 3118
Patent
active
058377352
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INDUSTRIAL USE
The present invention relates to an antiinflammatory agent for external use comprising nimesulide as an active ingredient. In particular, the present invention relates to an antiinflammatory agent for external use comprising nimesulide as an active ingredient and a base component wherein the nimesulide is mixed in a dispersed state in the base component, as well as to a process for preparing the same.
PRIOR ART
Non-steroidal antiinflammatory preparations have a disadvantage that, when orally administered, they cause gastrointestinal tract disorders. In order to avoid this disadvantage, various studies have been made to develop antiinflammatory agent for external use and several commercial products have been provided for clinical use. However, the antiinflammatory agent for external use hitherto developed have insufficient clinical effects even if they show effects in the basic tests.
Nimesulide (4-nitro-2-phenoxymethanesulfonanilide), which is one of the non-steroidal antiinflammatory agents, was first synthesized by Riker Co. in the United States and then developed as an oral preparation in Europe by Helsinn Co. in Switzerland. Being different from the conventional acidic antiinflammatory agents, it is known that nimesulide selectively inhibits PGE2 (COX2) and this is a new type of pharmaceutical agent expected to take effects in clinical use.
As the prior art regarding nimesulide, the substance patent described in U.S. Pat. No. 3,840,597 and process patents described in the examined Japanese patent publication (Kokoku) Sho-58-35989, the examined Japanese patent publication (Kokoku) Sho-58-50984 and the examined Japanese patent publication (Kokoku) Sho-59-44311 may be cited. However, these prior art references do not have descriptions or working examples regarding the actual pharmaceutical preparations, although they mention dosage forms such as capsule, cream, gel, tape, and the like.
In addition, the laid-open Japanese patent application (Kohyo) Hei-6-502842 based on the international patent application may be cited as a reference relating to the pharmaceutical preparation of nimesulide. This patent is to prepare an inclusion compound of nimesulide with cyclodextrin to make nimesulide water-soluble so as to increase water-solubility and to increase absorption of nimesulide in the gastrointestinal tract. Therefore, its object is not the external use. Thus, no reference is known which illustratively discloses use of nimesulide as an external preparation, and no case is known with respect to the actual external use of nimesulide in a particular dosage form.
It would be due to the fact that, although nimesulide has pharmacological effects equal to or higher than those of indomethacin which is regarded as a potent antiinflammatory agent, it has several unsolved problems when topically applied as an external preparation. That is, (1) nimesulide is hardly soluble and is not easily dissolved in water and various organic solvents. (2) A solvent which has strong solubilizing ability should be mixed to dissolve nimesulide, causing problems such as skin irritation, chapped skin, itch, and flare. (3) Even if nimesulide is dissolved, the resulting pharmaceutical preparation becomes deep yellow and thus its appearance becomes bad. (4) The pharmaceutical preparation applied soils clothes that contact the preparation.
Thus, there is a situation that the attempt to use nimesulide as the external preparation was abandoned.
Problems to be Solved by the Invention
The object of the present invention is to obtain an antiinflammatory agent for external use including nimesulide for topical use, which is a nimesulide external preparation showing excellent absorption and having no problem in coloring and skin safety.
Means for Solving the Problems
As a result of extensive studies taking the above-described disadvantages of nimesulide as an external preparation into consideration, the present inventors found that the above-described disadvantages are all solved when nimesulide is mixed in a disperse
REFERENCES:
patent: 3840597 (1974-10-01), Moore et al.
Kawamura Yoichi
Masuda Kenji
Miyata Satoru
Taniguchi Yasuaki
Helsinn Healthcare S.A.
Schenkman Leonard
LandOfFree
Antiinflammatory agent for external use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiinflammatory agent for external use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiinflammatory agent for external use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-884826